Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II)
Author:
Affiliation:
1. From the Heart Institute of the University of São Paulo (W.H., N.L., P.R.S., E.E.R., A.C.P., D.F., A.S.C.R., A.C.H., J.A.F.R.), São Paulo, Brazil, and the Mayo Clinic (B.J.G.), Rochester, Minn.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference24 articles.
1. Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease
2. Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease
3. Five-Year Follow-Up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II)
4. Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
5. Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II)
Cited by 295 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Octopus follow-up: 20 year prognosis in patients randomized to on-pump CABG, off-pump CABG or PCI;International Journal of Cardiology;2024-11
2. Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry;Heart;2024-08-30
3. Increased coronary artery disease severity in patients undergoing invasive diagnostics during the COVID-19 pandemic;Medycyna Pracy;2024-08-28
4. Utility of coronary revascularization in patients with ischemic left ventricular dysfunction;Cardiovascular Revascularization Medicine;2024-08
5. An updated meta-analysis of optimal medical therapy with or without invasive therapy in patients with stable coronary artery disease;BMC Cardiovascular Disorders;2024-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3